PFES Logo Patient & Family Education
Our Words.    Our Care.    Online.

Omalizumab (Xolair)  
Abstract:  This handout describes omalizumab, an injectable medicine for patients who have allergic asthma. This medicine is used in combination with other inhaled asthma medicines. Side effects and the possibility of anaphylaxis are discussed.
Author: Pulmonary Clinic/Med Spec Center
Publisher/Date/Rev:  University of Washington Medical Center, 2010, January 1, 2010
UWMC Availability:  Pulmonary Clinic/Med Spec Center; Pharmacy Services
General Topics:  Respiratory Disorders; Patient Care Procedures & Instructions
Specific Subject(s):  Side Effects; Medication Teaching; Medication Information; Medication; Injections; Asthma; Anaphylaxis
Language(s):  English
Audience:  Caregiver; Patient
Format: Flyer
Reading Level: Technical
Cost: Unknown
Web Site Location:

Health Online Citation #3720

To Order Copies:
Please reference Citation number listed above when ordering copies of this document.

UWMC-authored: Print document from this Web site, or contact authoring department for master. For multiple copies, contact UWMC Copy Services, 206-598-4019.

Non-UWMC authored: For photocopy or information, contact PFES, 206-598-7498; or contact the department listed in the "UWMC Availability" field above.

The health education materials accessed through this site are not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your doctor or other health care provider with any questions you may have about a medical condition.
If you think you have a medical emergency, call your doctor or 9-1-1 immediately.